Auf dieser Seite
DNTH Dianthus Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$88,21
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$32,2252-Wochen-Tief
$117,8852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$4.83B
P/E
-21.0
EPS
$-4.20
Umsatz
$2M
Ihre Abzeichen
52W-Spanne
$32–$118
Analystenbewertung
BUY
Kursziel
$141
P/E
-21.0
ROE
-40.8%
Nettogewinnmarge
-7973.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
DNTH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$88.21
Marktkapitalisierung (MRQ)
$4.83B
P/E
-21.0
EPS
$-4.20
Umsatz
$2M
ROE
-40.8%
52W-Spanne
$32–$118
DNTH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Dianthus Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter92
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2M2016-12-31 → 2025-12-31
EPS$-4.202020-12-31 → 2025-12-31
Freier Cashflow·2018-12-31 → 2021-12-31
Nettogewinnmarge-7973.3%2024-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | DNTH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -21.05-Jahres-Durchschnitt ≈-14.9 | ≈-14.9 | · | · | |
| P/S | 1872.65-Jahres-Durchschnitt ≈346.1 | ≈346.1 | 55.0 | Überbewertet | |
| K/B (MRQ) | 4.15-Jahres-Durchschnitt ≈7.6 | ≈7.6 | 8.1 | Unterbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -29.55-Jahres-Durchschnitt ≈-24.2 | ≈-24.2 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 7.75-Jahres-Durchschnitt ≈2.1 | ≈2.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | DNTH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Operating Margin (Betriebsgewinnmarge) | -8739.3% | · | -101.3% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -8739.3% | · | -101.3% | Schwach | |
| Net Profit Margin (Nettogewinnmarge) | -7973.3% | · | -100.5% | Schwach | |
| ROA | -35.9%5-Jahres-Durchschnitt ≈-35.1% | ≈-35.1% | -28.1% | Schwach | |
| ROE | -40.8%5-Jahres-Durchschnitt ≈-32.4% | ≈-32.4% | -41.5% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | DNTH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 26.15-Jahres-Durchschnitt ≈15.9 | ≈15.9 | 6.5 | Starke Liquidität | |
| Quick Ratio (MRQ) | 25.85-Jahres-Durchschnitt ≈15.6 | ≈15.6 | 2.9 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | DNTH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -67.3% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | DNTH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.0 | · | 0.2 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 78.3 | · | 9.7 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$22.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.5%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.90 | $-0.87 | -2.9% |
| 31. März 2026 | Mai 11, 2026 | $-0.85 | $-1.09 | 22.3% |
| 31. Dezember 2025 | $-1.43 | $-1.10 | -30.3% | |
| 30. September 2025 | $-0.97 | $-0.88 | -10.3% | |
| 30. Juni 2025 | $-0.88 | $-0.89 | 1.0% | |
| 31. März 2025 | $-0.82 | $-0.87 | 5.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $6M | $3M | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $146M | $83M | $33M | $29M | $47M | $51M | $59M | $41M | $28M | |
| SG&A Expense | $34M | $25M | $18M | $7M | $28M | $28M | $24M | $19M | $8M | |
| Operating Expenses | $180M | $108M | $51M | $36M | $75M | $79M | $83M | $60M | $36M | |
| Operating Income | $-178M | $-102M | $-48M | $-30M | $-75M | $-79M | $-83M | $-60M | $-36M | |
| Interest Income | $16M | $17M | $5M | · | · | · | · | · | · | |
| Other Non-op | $-974.0K | $-554.0K | $-60.0K | $-52.0K | · | · | · | $2M | $236.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | $-35M | |
| EPS (Basic) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| EPS (Diluted) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| Shares (Basic) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| Shares (Diluted) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| EBITDA | $-178M | $-102M | $-48M | · | $-73M | $-77M | $-81M | $-59M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $23M | $132M | $15M | $132M | $58M | $65M | $58M | $51M | |
| Short-term Investments | $353M | $252M | $41M | $60M | $45M | $91M | $81M | $84M | · | |
| Receivables | $52.0K | $0 | $294.0K | $5M | · | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $3M | $905.0K | $4M | $3M | $4M | $3M | $936.0K | |
| Other Current Assets | $86.0K | $355.0K | $0 | · | · | · | · | · | · | |
| Current Assets | $409M | $281M | $177M | $82M | $181M | $152M | $150M | $145M | $53M | |
| PP&E (Net) | $296.0K | $194.0K | $185.0K | $142.0K | $7M | $8M | $10M | $10M | $2M | |
| PP&E (Gross) | $600.0K | $387.0K | $282.0K | $172.0K | $14M | $13M | $13M | $11M | $2M | |
| Accum. Depreciation | $304.0K | $193.0K | $97.0K | $30.0K | $7M | $5M | $3M | $1M | $382.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $4.0K | |
| Total Assets | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Accounts Payable | $10M | $5M | $3M | $1M | $3M | $4M | $3M | $3M | $167.0K | |
| Accrued Liabilities | $19M | $13M | $7M | $7M | $8M | $8M | $11M | $7M | $4M | |
| Current Liabilities | $31M | $18M | $10M | $8M | $11M | $11M | $14M | $10M | $4M | |
| Capital Leases | $1M | $1M | $168.0K | $438.0K | $0 | · | · | · | · | |
| Total Liabilities | $38M | $22M | $11M | $9M | $17M | $18M | $20M | $12M | $4M | |
| Common Stock | $43.0K | $31.0K | $15.0K | $0 | $59.0K | $49.0K | $39.0K | $33.0K | $2.0K | |
| Retained Earnings | $-337M | $-174M | $-89M | $-46M | $-326M | $-254M | $-179M | $-103M | $-45M | |
| AOCI | $489.0K | $106.0K | $47.0K | $-161.0K | $-30.0K | $-23.0K | $8.0K | $-8.0K | · | |
| Stockholders' Equity | $493M | $352M | $169M | $-44M | $-17M | $144M | $141M | $146M | $-42M | |
| Liabilities + Equity | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Shares Outstanding | 43,223,090 | 31,115,341 | 14,817,696 | 875,279 | 58,799,157 | 48,533,135 | 39,260,532 | 33,305,033 | 2,351,247 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $875.0K | $376.0K | |
| Stock-based Comp | $23M | $13M | $3M | $2M | $10M | $10M | $10M | $11M | $2M | |
| Other Non-cash | · | · | · | · | $-723.0K | $-1M | $8M | $4M | · | |
| Operating Cash Flow | $-129M | $-78M | $-37M | $-29M | $-60M | $-64M | $-57M | $-42M | $-22M | |
| CapEx | · | · | · | $314.0K | $1M | $400.0K | $3M | $8M | $2M | |
| Investing Cash Flow | $-123M | $-287M | $20M | $-60M | $43M | $-11M | $2M | $-92M | $-2M | |
| Stock Issued | $317.0K | $0 | $0 | $3M | $0 | $65M | $61M | $93M | · | |
| Net Stock Activity | $317.0K | $39M | · | · | · | $65M | $61M | · | · | |
| Financing Cash Flow | $280M | $256M | $134M | $97M | $90M | $68M | $62M | $142M | $71M | |
| Net Change in Cash | $28M | $-109M | $117M | $8M | $73M | $-7M | $7M | $9M | $47M | |
| Taxes Paid | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-61M | $-64M | $-60M | $-50M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| Net Margin | -7973.3% | -1362.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| ROA | -35.9% | -30.7% | -33.2% | · | -40.5% | -46.4% | -48.2% | -54.3% | · | |
| ROE | -40.8% | -24.6% | -25.1% | · | -39.3% | -49.5% | -50.7% | -37.7% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 15.2 | 18.4 | · | 16.6 | 13.3 | 10.6 | 13.9 | · | |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 | 13.0 | 10.3 | 13.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 78.3 | 11.3 | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.42 | $11.33 | $11.40 | · | $2.94 | $2.97 | $3.60 | $4.37 | · | |
| Revenue / Share | $0.05 | $0.19 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.34 | $-2.35 | $-7.15 | · | $-1.08 | · | · | · | · | |
| Cash / Share | $1.18 | $0.73 | $8.93 | · | $2.24 | $1.20 | $1.66 | $1.75 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | |
| EPS (TTM) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.3% | 120.6% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $6M | $3M | · | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | · | |
| Market Cap | $1.78B | $678M | $154M | · | $4.17B | $6.09B | $9.52B | $3.04B | · | |
| P/E | -9.8 | -8.5 | -1.2 | -0.2 | -54.9 | -73.4 | · | · | · | |
| P/S | 874.9 | 108.8 | 54.5 | · | · | · | · | · | · | |
| P/B | 3.6 | 1.9 | 0.9 | · | 24.1 | 42.3 | 67.4 | 20.9 | · | |
| P / Tangible Book | 3.6 | 1.9 | 0.9 | · | · | 42.3 | · | · | · | |
| P / Cash Flow | -13.8 | -8.7 | -4.2 | · | -70.0 | -95.1 | -166.8 | -72.5 | · | |
| P / FCF | · | · | · | · | -68.6 | -94.5 | -158.3 | -61.3 | · | |
| Earnings Yield | -10.2% | -11.7% | -81.2% | -508.9% | -1.8% | -1.4% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $284.0K | $396.0K | $193.0K | $1M | $1M | $2M | $2M | $874.0K | $457.0K | $924.0K | · | · | · | $1M | |
| R&D Expense | $49M | $35M | $60M | $32M | $26M | $27M | $26M | $26M | $18M | $13M | $9M | $8M | $10M | $6M | $-6M | $7M | |
| SG&A Expense | $14M | $12M | $10M | $8M | $9M | $7M | $7M | $7M | $6M | $6M | $5M | $9M | $2M | $2M | $-9M | $2M | |
| Operating Expenses | $62M | $47M | $70M | $41M | $35M | $34M | $33M | $32M | $24M | $19M | $13M | $17M | $13M | $8M | $-15M | $9M | |
| Operating Income | $-61M | $-47M | $-70M | $-40M | $-35M | $-33M | $-32M | $-30M | $-22M | $-18M | $-13M | $-16M | $-12M | $-8M | $20M | $-8M | |
| Interest Income | $12M | $6M | $11M | $1M | $3M | $4M | $7M | $2M | $4M | $4M | · | · | · | · | · | · | |
| Other Non-op | $-370.0K | $-249.0K | $-409.0K | $-360.0K | $-107.0K | $-98.0K | $-382.0K | $22.0K | $-80.0K | $-114.0K | $-19.0K | $-15.0K | $-23.0K | $-3.0K | $-43.0K | $-2.0K | |
| Net Income | $-50M | $-41M | $-64M | $-37M | $-32M | $-30M | $-28M | $-25M | $-18M | $-14M | $-11M | $-15M | $-11M | $-7M | $-10M | $-8M | |
| EPS (Basic) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| EPS (Diluted) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| Shares (Basic) | 56,029,124 | 48,032,742 | · | 37,794,088 | 35,822,308 | 35,790,700 | · | 34,236,728 | 34,227,038 | 25,665,475 | · | 3,906,886 | 874,900 | 874,709 | · | 874,327 | |
| Shares (Diluted) | 56,029,124 | 48,032,742 | · | 37,794,088 | 35,822,308 | 35,790,700 | · | 34,236,728 | 34,227,038 | 25,665,475 | · | 3,906,886 | 874,900 | 874,709 | · | 874,327 | |
| EBITDA | $-61M | $-47M | · | $-40M | $-35M | $-33M | · | $-30M | $-22M | $-18M | · | $-16M | $-7M | $-32M | · | $-17M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $628M | $51M | $56M | $13M | $10M | $23M | $34M | $314M | $330M | $132M | $157M | $63M | $49M | $15M | $59M | |
| Short-term Investments | $776M | $484M | $353M | $347M | $244M | $253M | $252M | $247M | $47M | $47M | $41M | $33M | · | · | $60M | $69M | |
| Receivables | $106.0K | $1M | $52.0K | $5M | $39.0K | $1M | $0 | $1M | $840.0K | $435.0K | $294.0K | $232.0K | · | · | $5M | · | |
| Prepaid Expense | $11M | $7M | $5M | $6M | $6M | $7M | $5M | $4M | $3M | $3M | $3M | $832.0K | $1M | $3M | $905.0K | $4M | |
| Other Current Assets | $184.0K | $83.0K | $86.0K | $73.0K | $111.0K | $392.0K | $355.0K | · | · | · | $0 | · | · | · | · | · | |
| Current Assets | $898M | $1.12B | $409M | $414M | $264M | $271M | $281M | $287M | $366M | $381M | $177M | $191M | $79M | $83M | $82M | $132M | |
| PP&E (Net) | $418.0K | $274.0K | $296.0K | $185.0K | $207.0K | $191.0K | $194.0K | $189.0K | $189.0K | $195.0K | $185.0K | $195.0K | $0 | $0 | $142.0K | $6M | |
| PP&E (Gross) | $791.0K | $610.0K | $600.0K | $462.0K | $457.0K | $411.0K | $387.0K | $356.0K | $331.0K | $314.0K | $282.0K | $272.0K | · | · | $172.0K | · | |
| Accum. Depreciation | $373.0K | $336.0K | $304.0K | $277.0K | $250.0K | $220.0K | $193.0K | $167.0K | $142.0K | $119.0K | $97.0K | $77.0K | · | · | $30.0K | · | |
| Total Assets | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Accounts Payable | $6M | $5M | $10M | $7M | $5M | $8M | $5M | $8M | $4M | $3M | $3M | $1M | $813.0K | $1M | $1M | $3M | |
| Accrued Liabilities | $26M | $31M | $19M | $16M | $14M | $8M | $13M | $8M | $6M | $6M | $7M | $11M | · | · | $7M | $7M | |
| Current Liabilities | $34M | $38M | $31M | $24M | $20M | $17M | $18M | $16M | $10M | $9M | $10M | $13M | $4M | $6M | $8M | $13M | |
| Capital Leases | $913.0K | $965.0K | $1M | $1M | $1M | $1M | $1M | $0 | $30.0K | $97.0K | $168.0K | $257.0K | $0 | $0 | $438.0K | $27M | |
| Total Liabilities | $41M | $46M | $38M | $31M | $23M | $20M | $22M | $16M | $11M | $10M | $11M | $14M | $4M | $6M | $9M | $40M | |
| Common Stock | $55.0K | $54.0K | $43.0K | $43.0K | $32.0K | $32.0K | $31.0K | $29.0K | $29.0K | $29.0K | $15.0K | $15.0K | $61.0K | $61.0K | $0 | $61.0K | |
| Retained Earnings | $-428M | $-378M | $-337M | $-272M | $-236M | $-204M | $-174M | $-146M | $-121M | $-103M | $-89M | $-79M | $-434M | $-431M | $-46M | $-382M | |
| AOCI | $-2M | $-575.0K | $489.0K | $163.0K | $98.0K | $270.0K | $106.0K | $681.0K | $-37.0K | $-27.0K | $47.0K | $-4.0K | $-3.0K | $-16.0K | $-161.0K | $-462.0K | |
| Stockholders' Equity | $1.17B | $1.20B | $493M | $546M | $303M | $329M | $352M | $338M | $358M | $373M | $169M | $178M | $75M | $77M | $-44M | $124M | |
| Liabilities + Equity | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Shares Outstanding | 54,798,338 | 54,582,749 | 43,223,090 | 42,854,563 | 32,176,482 | 32,125,933 | 31,115,341 | 29,366,352 | 29,352,140 | 29,348,626 | 14,817,696 | 14,817,762 | 60,652,197 | 60,648,821 | 875,279 | 60,555,520 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $421.0K | · | $471.0K | |
| Stock-based Comp | $12M | $11M | $6M | $6M | $6M | $5M | $4M | $4M | $3M | $2M | $726.0K | $1M | $489.0K | $533.0K | $513.0K | $-3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $18M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-49M | $-29M | $-47M | $-31M | $-24M | $-28M | $-27M | $-21M | $-15M | $-15M | $-12M | $17M | $21M | $-10M | $-9M | $16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $245.0K | · | $158.0K | |
| Investing Cash Flow | $-479M | $-134M | $37M | $-201M | $26M | $15M | $-23M | $-259M | $1M | $-6M | $-8M | $-17M | $13M | $18M | $-13M | $-7M | |
| Stock Issued | $0 | $120.0K | $1.0K | $187.0K | $0 | $129.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $120.0K | · | · | · | $129.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $739M | $5M | $275M | $568.0K | $161.0K | $40M | $296.0K | $-2M | $218M | $-5M | $138M | $0 | $0 | $0 | $97M | |
| Net Change in Cash | $-517M | $577M | $-5M | $43M | $3M | $-13M | $-11M | $-280M | $-16M | $197M | $-25M | $139M | $34M | $8M | $-22M | $106M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| Net Margin | · | · | · | -9284.1% | -16388.1% | -2537.5% | · | · | · | · | · | -1597.7% | · | · | · | · | |
| EBITDA Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| ROA | -6.5% | -5.1% | · | -7.9% | -9.1% | -8.1% | · | -9.2% | -7.9% | -5.9% | · | -8.3% | -2.6% | -21.0% | · | -8.7% | |
| ROE | -6.8% | -5.3% | · | -8.3% | -9.6% | -8.4% | · | -9.8% | -8.1% | -6.1% | · | -9.8% | -3.1% | -25.5% | · | -10.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.1 | 29.3 | · | 17.3 | 13.1 | 16.0 | · | 18.3 | 36.5 | 42.5 | · | 14.6 | 19.5 | 13.9 | · | 10.2 | |
| Quick Ratio | 25.8 | 29.1 | · | 17.1 | 12.8 | 15.6 | · | 18.0 | 36.1 | 42.1 | · | 14.5 | 15.5 | 8.1 | · | 9.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | 0.1 | 0.4 | 1.6 | · | · | · | · | · | 8.0 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.39 | $22.01 | · | $12.75 | $9.42 | $10.23 | · | $11.51 | $12.20 | $12.70 | · | $12.04 | $1.23 | $1.28 | · | $2.05 | |
| Revenue / Share | · | · | · | $0.01 | $0.01 | $0.03 | · | · | · | · | · | $0.24 | · | · | · | · | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.77 | · | · | · | $-0.58 | · | · | · | $-0.59 | · | · | |
| Cash / Share | $2.02 | $11.50 | · | $1.31 | $0.41 | $0.31 | · | $1.15 | $10.70 | $11.23 | · | $10.61 | $1.03 | $0.80 | · | $0.97 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | |
| EPS (TTM) | $-4.25 | $-4.23 | · | $-3.43 | $-3.20 | $-2.83 | · | $14.37 | $11.33 | $-0.89 | · | $-47.60 | $-52.72 | $-40.28 | · | $-9.89 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $3M | $5M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | |
| Net Income TTM | $-192M | $-174M | · | $-126M | $-115M | $-101M | · | $-67M | $-57M | $-50M | · | $-43M | $-36M | $-31M | · | $-38M | |
| Market Cap | $5.34B | $4.58B | · | $1.69B | $599M | $583M | · | $804M | $760M | $880M | · | $203M | $738M | $767M | · | $1.37B | |
| P/E | -22.9 | -19.8 | · | -11.5 | -5.8 | -6.4 | · | 1.9 | 2.3 | -33.7 | · | -0.3 | -0.2 | -0.3 | · | -2.3 | |
| P/S | 2623.6 | 2249.8 | · | 547.9 | 123.5 | 89.3 | · | 149.8 | 184.5 | · | · | · | · | · | · | · | |
| P/B | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Tangible Book | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Cash Flow | · | -158.7 | · | · | · | -21.1 | · | · | · | -58.9 | · | · | · | -21.5 | · | · | |
| Earnings Yield | -4.4% | -5.0% | · | -8.7% | -17.2% | -15.6% | · | 52.5% | 43.8% | -3.0% | · | -348.2% | -433.5% | -318.7% | · | -43.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2M | $6M | $3M | · | · |
| Betriebsgewinnmarge % | -8739.3% | -1633.7% | · | · | · |
| Nettoergebnis | $-162M | $-85M | $-44M | $-28M | $-71M |
| Verwässerte EPS | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 13.3 | 15.2 | 18.4 | · | 16.6 |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | · | $-61M |
Institutionelle Eigentümer (13F) 284 Einreicher · $5.9B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
284
Gehaltener Wert
$5.9B
Neue Positionen
61
Geschlossene Positionen
31
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 61 (-43 vs. Vorquartal) | 31 (+14 vs. Vorquartal) | 121 (+38 vs. Vorquartal) | 67 (+14 vs. Vorquartal) | +4.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $799.325.570 | 8.199.893 | 13,66% | Aktien |
| BlackRock, Inc. | $401.990.169 | 4.123.822 | 6,87% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $314.848.897 | 3.229.882 | 5,38% | Aktien |
| Fairmount Funds Management LLC | $247.325.379 | 2.537.191 | 4,23% | Aktien |
| STATE STREET CORP | $229.798.634 | 2.357.440 | 3,93% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $210.514.689 | 2.159.568 | 3,60% | Aktien |
| Avidity Partners Management LP | $205.115.856 | 2.104.184 | 3,50% | Aktien |
| Octagon Capital Advisors LP | $179.525.699 | 1.841.667 | 3,07% | Aktien |
| TCG Crossover Management, LLC | $163.437.308 | 1.676.624 | 2,79% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $126.967.018 | 1.302.493 | 2,17% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $122.696.604 | 1.258.502 | 2,10% | Aktien |
| Venrock Adviser, LLC | $115.026.400 | 1.180.000 | 1,97% | Aktien |
| UBS Group AG | $111.152.545 | 1.140.260 | 1,90% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $109.695.511 | 1.125.313 | 1,87% | Aktien |
| JENNISON ASSOCIATES LLC | $99.601.453 | 1.021.763 | 1,70% | Aktien |
| Polar Capital Holdings Plc | $99.305.410 | 1.018.726 | 1,70% | Aktien |
| CITADEL ADVISORS LLC | $95.034.324 | 974.911 | 1,62% | Aktien |
| FRANKLIN RESOURCES INC | $94.456.440 | 968.983 | 1,61% | Aktien |
| VANGUARD GROUP INC | $84.416.707 | 2.048.452 | 1,44% | Aktien |
| BAKER BROS. ADVISORS LP | $83.068.947 | 852.164 | 1,42% | Aktien |
| Logos Global Management LP | $77.984.000 | 800.000 | 1,33% | Aktien |
| Cormorant Asset Management, LP | $73.110.000 | 750.000 | 1,25% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $70.001.868 | 834.150 | 1,20% | Aktien |
| BRAIDWELL LP | $57.957.904 | 594.562 | 0,99% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55.574.810 | 570.115 | 0,95% | Aktien |
| AMERIPRISE FINANCIAL INC | $51.859.546 | 531.999 | 0,89% | Aktien |
| Woodline Partners LP | $48.793.419 | 500.548 | 0,83% | Aktien |
| BARCLAYS PLC | $42.087.284 | 431.753 | 0,72% | Aktien |
| MPM BIOIMPACT LLC | $40.941.795 | 420.002 | 0,70% | Aktien |
| NORTHERN TRUST CORP | $40.141.386 | 411.791 | 0,69% | Aktien |
| Affinity Asset Advisors, LLC | $38.992.000 | 400.000 | 0,67% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $38.017.200 | 390.000 | 0,65% | Aktien |
| GOLDMAN SACHS GROUP INC | $37.253.054 | 382.161 | 0,64% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35.674.073 | 365.963 | 0,61% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $35.333.576 | 362.470 | 0,60% | Aktien |
| Spruce Street Capital LP | $34.587.464 | 354.816 | 0,59% | Aktien |
| Vivo Capital, LLC | $34.507.725 | 353.998 | 0,59% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $31.334.301 | 321.503 | 0,54% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $30.697.817 | 314.914 | 0,52% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $29.485.945 | 302.482 | 0,50% | Aktien |
| Driehaus Capital Management LLC | $28.782.530 | 295.266 | 0,49% | Aktien |
| First Turn Management, LLC | $27.856.957 | 285.771 | 0,48% | Aktien |
| Assenagon Asset Management S.A. | $27.357.665 | 280.649 | 0,47% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $25.802.176 | 264.692 | 0,44% | Aktien |
| Artisan Partners Limited Partnership | $25.176.062 | 258.269 | 0,43% | Aktien |
| BANK OF AMERICA CORP /DE/ | $25.036.081 | 256.833 | 0,43% | Aktien |
| Bank of New York Mellon Corp | $24.993.153 | 256.393 | 0,43% | Aktien |
| RTW INVESTMENTS, LP | $24.181.181 | 248.063 | 0,41% | Aktien |
| EMERALD ADVISERS, LLC | $24.156.031 | 247.805 | 0,41% | Aktien |
| Pictet Asset Management Holding SA | $24.106.317 | 247.295 | 0,41% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×5 Einreichungen | 25. November 2025 | 4,90% | Änderung | · | SEC |
| Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC, Avidity Private Master Fund I LP, Michael Gregory ×4 Einreichungen | 19. November 2025 | 4,90% | Änderung | Passive Anlage | SEC |
| Viridian, LLC ×2 Einreichungen | 12. September 2024 | · | Erste Einreichung | · | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×4 Einreichungen | 15. September 2023 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 36 Insider · 13 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Marino Garcia | CEO AND PRESIDENT | 7. August 2026 M | 65.292 | 0 | 12 | $-27.961.831 |
| Ryan Savitz | EVP, CFO & CBO | 9. Juli 2026 M | 0 | 0 | 13 | $-14.292.190 |
| Edward Carr | CHIEF ACCOUNTING OFFICER | 17. September 2026 M | 0 | 0 | 10 | $-5.587.140 |
| Simrat Randhawa | EVP, Head of R&D | 1. September 2026 M | 4.000 | 0 | 11 | $-15.001.124 |
| Adam M Veness | SVP, General Counsel and Sec. | 13. August 2026 M | 15.000 | 0 | 5 | $-4.632.790 |
| David Wayne Nichols | Chief Technical Officer | 1. August 2022 A | 14.306 | 0 | 0 | $0 |
| Lisa Olson | Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney | 1. August 2022 A | 14.264 | 0 | 0 | $0 |
| Jeffrey Humphrey | Chief Medical Officer | 1. August 2022 A | · | 0 | 0 | $0 |
| John C. Davis JR | Title: Head of Research and Development and Chief Medical Officer | 11. Februar 2021 A | 8.304 | 0 | 0 | $0 |
| Zoran Zdraveski | Title: Secretary and Chief Legal and Technology Operations Officer | 11. Februar 2021 A | 133.010 | 0 | 0 | $0 |
| Christina K. Isacson | Chief Business Officer | 10. Februar 2020 A | 83.786 | 0 | 0 | $0 |
| Jason Ryan | Title: Chief Operating and Financial Officer | 10. Februar 2020 A | · | 0 | 0 | $0 |
| COOKE MICHAEL P. | Chief Scientific Officer | 2. Dezember 2019 S | 240.523 | 0 | 0 | $0 |
| Simon Read | Direktor | 19. August 2026 M | 0 | 0 | 7 | $-630.786 |
| Anne Mcgeorge | Direktor | 10. August 2026 M | 0 | 0 | 5 | $-844.822 |
| Jonathan Violin | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Paula Soteropoulos | Direktor | 21. Mai 2026 A | 0 | 0 | 3 | $-2.252.895 |
| Steven J. Romano | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Alison Frances Lawton | Direktor | 21. Mai 2026 A | · | 0 | 0 | $0 |
| MOULDER LEON O JR | Direktor | 23. Mai 2024 A | 1.436.745 | 0 | 0 | $0 |
| Michael Vasconcelles | Direktor | 15. August 2022 A | · | 0 | 0 | $0 |
| David Scadden | Direktor | 28. Juni 2022 A | 228.175 | 0 | 0 | $0 |
| Jeffrey W. Albers | Direktor | 28. Juni 2022 A | 4.152 | 0 | 0 | $0 |
| Thomas O Daniel | Direktor | 28. Juni 2022 A | 101.926 | 0 | 0 | $0 |
| Bruce Booth | Direktor | 28. Juni 2022 A | 1.250.000 | 0 | 0 | $0 |
| Amy L Ronneberg | Direktor | 28. Juni 2022 A | 593.611 | 0 | 0 | $0 |
| Alexis Borisy | Direktor | 26. August 2021 J | 4.100 | 0 | 0 | $0 |
| Michael W Bonney | Direktor | 1. Juni 2021 A | 215.346 | 0 | 0 | $0 |
| Blake Byers | Direktor | 5. Juni 2020 A | 3.339.137 | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | 10%-Eigentümer | 11. Februar 2021 J | 3.148.399 | 0 | 0 | $0 |
| Sujay Kango | · | 21. Mai 2026 A | · | 0 | 0 | $0 |
| Caren Deardorf | · | 30. November 2022 A | 19.762 | 0 | 0 | $0 |
| Kristen Stants | · | 30. November 2022 A | 20.264 | 0 | 0 | $0 |
| Stephen F. Mahoney | · | 30. November 2022 A | 17.264 | 0 | 0 | $0 |
| Thomas W. Beetham | · | 30. November 2022 A | 19.897 | 0 | 0 | $0 |
| Jason Gardner | · | 30. November 2022 A | 292.872 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 37 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 5,04% | 3.652 SH | 11. September 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 1,90% | 62.115 SH | 2. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,96% | 44.156 NS | 31. Juli 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,87% | 3.787 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,53% | 24.335 SH | 2. Oktober 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,44% | 52.995 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,32% | 444.336 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,27% | 50.626 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,27% | 603 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1.463 NS | 31. Juli 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,17% | 23.108 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,16% | 22.655 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,16% | 1.209.461 SH | 11. September 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 10.325 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,15% | 29.943 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,14% | 272.370 SH | 19. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,14% | 17.898 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 4.800 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 16.364 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 17.465 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,05% | 110.607 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,05% | 71.218 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 457.520 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 10.691 SH | 2. Oktober 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 2.149 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,01% | 3.958 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.650.280 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.889 SH | 19. August 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 12.690 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,01% | 7.297 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 27.975 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 54.499 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 810 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 4.404 NS | 31. Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 1.709 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 8.427 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 2.457 SH | 19. August 2026 | Täglich |
DNTH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 22 Analysten
KAUF
Median-Ziel
$134.00
+51,9%
10 45,5%
Starker Kauf
11 50,0%
Kauf
1 4,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
15 Analysten · 2026-10-03Mittelwert-Ziel $140.80 +59,6%
← Unter allen Zielen
Aktueller Preis $88.21
Tief$122.00
Mittelwert$140.80
Hoch$200.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026